Stocklytics Platform
Asset logo for symbol RPRX
Royalty Pharma PLC
RPRX51
$32.31arrow_drop_down1.61%-$0.53
Asset logo for symbol RPRX
RPRX51

$32.31

arrow_drop_down1.61%

Income Statement (RPRX)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT-$735.07M$0.00-$689.81M$672.44M
EBITDA$362.00M$872.86M$560.00M$39.95M$673.86M
gross Profit$594.00M$563.03M$531.26M-$15.62M$519.48M
NET Income$208.00M$543.98M$102.00M$4.77M$494.34M
total Revenue$594.00M$564.69M$537.26M$567.97M$596.00M

Balance Sheet (RPRX)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt$6.68B$6.65B$5.83B$5.29B$5.65B
stockholders Equity$10.34B$6.86B$6.47B$6.49B$6.52B
total Assets$18.22B$18.04B$17.65B$16.13B$16.38B
total Debt$7.61B$7.60B$7.60B$6.13B$6.13B
total Liabilities$7.88B$7.78B$7.90B$6.26B$6.29B

Cash Flow (RPRX)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow-$258.00M-$325.50M$1.15B-$213.42M-$237.97M
free Cash Flow$743.00M$1.52B-$84.47M$583.51M-$224.95M
investing Cash Flow-----
operating Cash Flow$743.00M$703.61M$662.15M$669.60M$777.28M

Royalty Pharma PLC (RPRX) Financials

The income statement for Royalty Pharma PLC (RPRX) provides a snapshot of the company's financial performance. It shows the revenue generated from its operations and the expenses incurred to generate that revenue. The income statement also includes key measures such as EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). EBIT represents the company's operating income before deducting interest and taxes, while EBITDA adds back non-cash expenses like depreciation and amortization. These measures help assess the company's profitability and operating efficiency.
Another important figure on the income statement is the gross profit, which is the revenue minus the cost of goods sold. It indicates how much profit the company makes from its core operations. The net income from stockholders represents the profit that is attributable to the company's shareholders after deducting taxes and other expenses. Overall, the income statement provides a comprehensive view of the company's earnings, expenses, and profitability.
add Royalty Pharma PLC to watchlist

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level